{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T08:57:08Z","timestamp":1784883428655,"version":"3.55.0"},"reference-count":4,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T00:00:00Z","timestamp":1621900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T00:00:00Z","timestamp":1621900800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Hepatology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1002\/hep.31613","type":"journal-article","created":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T08:20:30Z","timestamp":1604391630000},"page":"2598-2600","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":33,"title":["Improved Markers of Cholestatic Liver Injury in Patients With Primary Biliary Cholangitis Treated With Obeticholic Acid and Bezafibrate"],"prefix":"10.1097","volume":"73","author":[{"given":"Lena","family":"Smets","sequence":"first","affiliation":[{"name":"Laboratory of Hepatology,CHROMETA Department,KU Leuven,Leuven,Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jef","family":"Verbeek","sequence":"additional","affiliation":[{"name":"Laboratory of Hepatology,CHROMETA Department,KU Leuven,Leuven,Belgium"},{"name":"Department of Gastroenterology and Hepatology,University Hospitals KU Leuven,Leuven,Belgium is part of the Members of the European Reference Networks RARE\u2010LIVER"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":",","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannelie","family":"Korf","sequence":"additional","affiliation":[{"name":"Laboratory of Hepatology,CHROMETA Department,KU Leuven,Leuven,Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Schalk","family":"van der Merwe","sequence":"additional","affiliation":[{"name":"Laboratory of Hepatology,CHROMETA Department,KU Leuven,Leuven,Belgium"},{"name":"Department of Gastroenterology and Hepatology,University Hospitals KU Leuven,Leuven,Belgium is part of the Members of the European Reference Networks RARE\u2010LIVER"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Nevens","sequence":"additional","affiliation":[{"name":"Laboratory of Hepatology,CHROMETA Department,KU Leuven,Leuven,Belgium"},{"name":"Department of Gastroenterology and Hepatology,University Hospitals KU Leuven,Leuven,Belgium is part of the Members of the European Reference Networks RARE\u2010LIVER"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,5,25]]},"reference":[{"key":"hep31613-bib-0001-20250824","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.14309\/ajg.0000000000000557","article-title":"Goals of treatment for improved survival in primary biliary cholangitis","volume":"115","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"hep31613-bib-0002-20250824","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A placebo\u2010controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","year":"2016","journal-title":"N Engl J Med"},{"key":"hep31613-bib-0003-20250824","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1056\/NEJMoa1714519","article-title":"A placebo\u2010controlled trial of bezafibrate in primary biliary cholangitis","volume":"378","year":"2018","journal-title":"N Engl J Med"},{"key":"hep31613-bib-0004-20250824","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/ajg.2017.287","article-title":"Effects of bezafibrate on outcome and pruritus in primary biliary cholangitis with suboptimal ursodeoxycholic acid response","volume":"113","year":"2018","journal-title":"Am J Gastroenterol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hep.31613","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hep.31613","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1002\/hep.31613","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:05:05Z","timestamp":1756080305000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1002\/hep.31613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,25]]},"references-count":4,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.31613","relation":{},"ISSN":["0270-9139","1527-3350"],"issn-type":[{"value":"0270-9139","type":"print"},{"value":"1527-3350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,25]]},"assertion":[{"value":"2020-04-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}